Webcast Accelerating Gene Variant Detection With Deep Learning

Accelerating Gene Variant Detection With Deep Learning

 · America/Los_Angeles

About This Webcast

Dr. Tychele Turner, from the Washington University School of Medicine in St. Louis, will present her lab's development of a computational workflow, called HAT, to detect de novo variants from whole-exome and whole-genome sequencing datasets. She’ll detail the development of this hybrid CPU/GPU workflow and discuss the application to >6,000 parent-child sequenced families. Dr. Turner will also describe her lab’s utilization of GPUs in detecting variants from long-read sequencing data. Dr. Turner’s talk will focus on areas of particular utility of GPU-based acceleration of genomic tools, including her lab’s use of NVIDIA Parabricks®, a suite of GPU-accelerated and deep learning industry-standard genomics analysis tools for next-generation sequencing data. In this webinar you will: Understand what a de novo variant is and how it is detected from sequencing data Learn key uses of deep learning-based variant calling to detect de novo variants Identify key differences between short- and long-read sequencing Learn key uses of GPU-based acceleration to assess long-read sequencing data NVIDIA Parabricks is free for anyone. Download it today to try it out on your DNA and RNA data. (C) NVIDIA Corporation 2023. All rights reserved. No recording of this webinar should be made or reposted without the express written consent of NVIDIA Corporation.

Speakers

Dr. Tychele Turner

Dr. Tychele Turner

PI/Assistant Professor , Washington University School of Medicine

Dr. Tychele Turner is a geneticist/genomicist with a deep interest in understanding the genetic architecture of human disease. Dr. Turner completed her undergraduate training in genomics and molecular genetics at Michigan State University, followed by graduate work at the Johns Hopkins University School of Medicine, where she received her Ph.D. in human genetics and molecular biology. She then performed her postdoctoral work in the Department of Genome Sciences at the University of Washington. In September 2019, Dr. Turner, an assistant professor, opened her independent laboratory in the Department of Genetics at Washington University School of Medicine in St. Louis. Her lab is currently focused on the study of noncoding variation in autism, precision genomics in 9p minus syndrome, optimization of genomic workflows, and the application of long-read sequencing to human genetics.

Harry Clifford

Harry Clifford

Product Manager for Clara Parabricks , NVIDIA

As the product lead for genomics at NVIDIA, Harry Clifford leverages NVIDIA’s expertise in AI, high performance computing (HPC), and data analytics stacks to bring HPC to the genomics field. His background is in bioinformatics and functional genomics, including a Ph.D. from the University of Oxford, post-doctoral experience in the biopharma industry and at the University of Cambridge, and entrepreneurial experience in the biotech sector. Clifford was listed in Forbes’ “30 Under 30” after co-founding precision oncology company CCG.ai (acquired by Dante Genomics), a Y Combinator and Merck Accelerator-backed startup delivering decision support via deep learning.